The past, present and future of anti-malarial medicines

EG Tse, M Korsik, MH Todd - Malaria journal, 2019 - Springer
Great progress has been made in recent years to reduce the high level of suffering caused
by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria …

Antimalarial drug discovery: Progress and approaches

JL Siqueira-Neto, KJ Wicht, K Chibale… - Nature Reviews Drug …, 2023 - nature.com
Recent antimalarial drug discovery has been a race to produce new medicines that
overcome emerging drug resistance, whilst considering safety and improving dosing …

Structural modification aimed for improving solubility of lead compounds in early phase drug discovery

B Das, ATK Baidya, AT Mathew, AK Yadav… - Bioorganic & Medicinal …, 2022 - Elsevier
Many lead compounds fail to reach clinical trials despite being potent because of low
bioavailability attributed to their insufficient solubility making solubility a primary and crucial …

Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review

V Yadav, J Reang, V Sharma, J Majeed… - Chemical Biology & …, 2022 - Wiley Online Library
The quinoline scaffolds are privileged for their numerous biological activities in the
pharmaceutical field. This moiety constitutes a well‐known space in several marketed …

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised …

JS McCarthy, Ö Yalkinoglu, A Odedra… - The Lancet Infectious …, 2021 - thelancet.com
Background M5717 is the first plasmodium translation elongation factor 2 inhibitor to reach
clinical development as an antimalarial. We aimed to characterise the safety …

Basic Nitrogen (BaN) is a key property of antimalarial chemical space

H Valluri, A Bhanot, S Shah, N Bhandaru… - Journal of Medicinal …, 2023 - ACS Publications
Most antimalarials are based on basic N-heterocycles and possess amine functionalities.
Despite this, the role of basic nitrogen (BaN) in antimalarial drug design has not been …

Screening the medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery

S Duffy, ML Sykes, AJ Jones, TB Shelper… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Open-access drug discovery provides a substantial resource for diseases primarily affecting
the poor and disadvantaged. The open-access Pathogen Box collection is comprised of …

High-throughput screening platform to identify inhibitors of protein synthesis with potential for the treatment of malaria

F Tamaki, F Fisher, R Milne, FSR Terán… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Artemisinin-based combination therapies have been crucial in driving down the global
burden of malaria, the world's largest parasitic killer. However, their efficacy is now …

Antimalarial drug discovery: from quinine to the most recent promising clinical drug candidates

C Tisnerat, A Dassonville-Klimpt… - Current Medicinal …, 2022 - ingentaconnect.com
Malaria is a tropical threatening disease caused by Plasmodium parasites, resulting in
409,000 deaths in 2019. The delay of mortality and morbidity has been compounded by the …

New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity

SH Abbas, AA Abd El-Hafeez, ME Shoman… - Bioorganic …, 2019 - Elsevier
A series of quinoline-chalcone hybrids was designed as potential anti-cancer agents,
synthesized and evaluated. Different cytotoxic assays revealed that compounds …